Quest Diagnostics financials at a glance

Year Year 2020 2021 2022 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2023 2024
Rev. Revenue
$9.44B $10.79B $9.88B $5.07B $5.46B $6.27B $6.70B $7.25B $7.46B $7.26B $7.39B $7.38B $7.15B $7.44B $7.49B $7.21B $7.40B $7.53B $7.73B $9.25B $0.00M
GM % Gross Margin %
39.39% 39.33% 35.08% 41.39% 40.98% 41.04% 40.85% 41.40% 42.03% 41.11% 41.27% 41.58% 40.06% 38.31% 38.72% 36.57% 36.40% 35.33% 35.26% 33.17% 0.00%
OM Operating Margin
22.33% 22.67% 15.70% 17.38% 18.58% 18.43% 16.50% 17.05% 18.05% 17.84% 17.56% 17.84% 16.18% 15.05% 16.07% 17.02% 16.18% 16.12% 15.78% 14.42% 0.00%
EPS Earnings Per Share
$2.66 $3.16 $2.91 $3.28 $3.93 $4.06 $4.53 $4.36 $4.00 $4.10 $4.77 $5.15 $5.67 $6.31 $6.56 $11.18 $14.24 $9.95 $8.71 $0.00
Div. Dividends
$2.24 $2.64 $2.64 $0.30 $0.36 $0.40 $0.40 $0.40 $0.40 $0.40 $0.47 $0.68 $1.20 $1.52 $1.52 $1.65 $1.80 $2.03 $2.12 $2.77 $0.00
PR % Payout Ratio %
20.04% 18.54% 26.53% 12.30% 13.53% 12.66% 13.75% 12.20% 10.18% 9.85% 10.38% 15.60% 30.00% 37.07% 31.87% 32.04% 31.75% 32.17% 32.32% 31.80% 0
Sha. Shares
133.73m 122.67m 113.89m 202.4m 202.09m 195.06m 193.6m 195.61m 184.9m 170m 157.76m 158.97m 145.43m 144.53m 143.35m 138.64m 136.3m 136.07m 134.7m 112.43m 111.06m
OCF Operating Cash Flow
$2.01B $2.23B $1.72B $798.78M $851.58M $951.90M $926.92M $1.06B $997.42M $1.12B $895.00M $1.19B $652.00M $944.00M $821.00M $1.12B $1.18B $1.20B $1.24B $1.27B $0.00M
FCF Free Cash Flow
$1.59B $1.83B $1.31B $622.65M $627.28M $758.50M $707.82M $850.35M $830.52M $913.00M $734.00M $1.00B $421.00M $630.00M $547.00M $776.00M $923.00M $817.00M $843.00M $920.97M $0.00M
FCFS Free Cash Flow Per Share
$11.84 $14.64 $11.33 $3.05 $3.11 $3.85 $3.66 $4.38 $4.47 $5.19 $4.62 $6.32 $5.89 $4.39 $3.88 $5.88 $6.74 $6.01 $6.29 $7.71 $0.00